A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

Background. Intrapartum single-dose (SD) nevirapine (NVP) reduces perinatal transmission of human immunodeficiency virus (HIV) infection but selects for NVP-resistant virus, which compromises subsequent NVP-based therapy. A 1-week “tail” of lamivudine and zidovudine after SD-NVP decreases the risk o...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Van Dyke, Russell B., Ngo-Giang-Huong, Nicole, Shapiro, David E., Frenkel, Lisa, Britto, Paula, Roongpisuthipong, Anuvat, Beck, Ingrid A., Yuthavisuthi, Praparb, Prommas, Sinart, Puthanakit, Thanyawee, Achalapong, Jullapong, Chotivanich, Nantasak, Rasri, Wirawan, Cressey, Tim R., Maupin, Robert, Mirochnick, Mark, Jourdain, Gonzague
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2012
Soggetti:
HIV/AIDS
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3245730/
https://ncbi.nlm.nih.gov/pubmed/22144539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cir798
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi